Search

everythinglearnresearchcommunity

for

Search:↓

Hair transplantation for Frontal Fibrosing Alopecia may work if done after the disease is inactive for 2 years and with ongoing treatment after surgery.

Targeting EGFR may help reduce hair loss from chemotherapy.

Found new possible treatments for hair loss.

Cicatricial alopecia involves scarring hair loss and can be treated with various medications.

Minoxidil helps stimulate hair growth and enlarge small follicles in common hair loss, but doesn't stop it, and its effects can be boosted when combined with finasteride.

Chronic stress and high cortisol levels can cause hair loss by disrupting hair growth.

Trichoscopy effectively diagnoses and monitors cicatricial alopecias, reducing the need for biopsies.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

New treatments for hair loss and excessive hair growth show promise with few side effects and advancements in laser technology.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Finasteride helps increase hair growth in men with hair loss.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Walter P. Unger suggests using advanced hair transplant techniques for broader coverage, as they provide natural results and use donor tissue efficiently, while also recommending personalized planning due to the unpredictable progression of baldness.

Scalp alopecia areata mostly affects young adult males, often starts suddenly, and usually presents as single, patchy lesions.

Treat hair loss with medicine, continue indefinitely.

Accurate diagnosis is crucial for effectively treating severe alopecia and related symptoms.

Finasteride and dutasteride may help prevent hair loss but could cause side effects like sexual dysfunction and psychological issues.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

A woman with a new PTCH gene mutation has both Gorlin syndrome and severe hair loss.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Alopecia areata cases in children are rising, especially in females and low-income regions, with a projected increase in China and decrease in the USA.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.